Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Blood System Drugs (Find 85 items)

Blood System Drugs

Isbogrel

(89667-40-3)
Thromboxane A2 inhibitor. Used to treat short-term myocardial ischemia.

Request for quotation , get quotes from more suppliers.

Coagulase

(9001-13-2)
Batroxobin for injection is mainly used clinically for bleeding before and after surgery, bleeding in the stomach and intestines, bleeding in various cancers and tumors, bleeding caused by drugs, bleeding from teeth extraction, and bleeding in newborns. But patients with a history of thrombosis or embolism are banned. Except for emergency bleeding, pregnant women should not use this product during the first 3 months of pregnancy. Intravenous injection, intramuscular injection or subcutaneous inj

Request for quotation , get quotes from more suppliers.

Hematological diseases refer to diseases that are primary (such as leukemia) or mainly involve blood (such as iron deficiency anemia) and hematopoietic organs. Classification: red blood cell diseases, such as various types of anemia and polycythemia, etc .; granulocyte diseases, such as leukopenia and agranulocytosis, neutrophil lobular insufficiency, inert leukocyte syndrome, and leukemia-like reactions. Blood system drugs mainly include: anti-anemic drugs, leukocyte-raising drugs, antiplatelet drugs, procoagulant drugs, anticoagulant drugs and thrombolytic drugs, blood volume expansion agents, leukocyte-raising drugs, antiplatelet drugs and other drugs. The "Blood System Drugs" on ECHEMI classification list mainly supplies APIs for these drugs.
Complaint
Email:
Message:
Send Message